Form 4 · Filed May 27, 2026, 10:28 PM UTC
ETON/Eton Pharmaceuticals, Inc.
Krempa David — Chief Business Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
15 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 27, 2026 | M | other | 7,203 | — | — | 118,406 |
| May 27, 2026 | M | other | 12,476 | $1 | $17,092 | 37,725 |
| May 27, 2026 | M | other | 7,203 | $4 | $25,787 | 44,928 |
| May 27, 2026 | S | sell | 19,679 | $31 | $619,375 | 25,249 |
| May 27, 2026 | M | other | 12,476 | — | — | 0 |
| May 26, 2026 | M | other | 12,524 | $1 | $17,158 | 62,773 |
| May 26, 2026 | S | sell | 37,524 | $31 | $1,181,732 | 25,249 |
| May 26, 2026 | M | other | 25,000 | — | — | 0 |
| May 26, 2026 | M | other | 12,524 | — | — | 12,476 |
| May 26, 2026 | M | other | 25,000 | $1 | $34,500 | 50,249 |
| May 22, 2026 | M | other | 30,591 | — | — | 125,609 |
| May 22, 2026 | S | sell | 32,963 | $33 | $1,095,057 | 35,083 |
| May 22, 2026 | S | sell | 9,315 | $34 | $315,594 | 25,768 |
| May 22, 2026 | S | sell | 519 | $35 | $18,165 | 25,249 |
| May 22, 2026 | M | other | 30,591 | $4 | $109,516 | 68,046 |
Source: SEC EDGAR raw filing ↗ · Accession 0001437749-26-018628